Commercial

Top 25 rare disease brands, by sales

Teva Pharmaceutical Industries' Copaxone is by far the top-selling drug, bringing in $3.2 billion in U.S. sales in 2015.

February 15, 2017

3:35 pm

From the March 01, 2017 Issue of MM+M - Medical Marketing and Media

From Our Partners

Partner Content

Thought leadership: The key to connecting with healthcare decision-makers

Organizations can partner with Advisory Board Sponsorship to create content and events that elevate their thought leadership.

Partner Content

Empowered engagement: How audience-centric strategies drive healthcare marketing success

During this conversation, hear from Swoop and Bayer about how brands can think differently about their targeting strategies to optimize engagement, improve patient outcomes, and drive Rx lift.

Partner Content

Will pharma finally reach out to minorities before the government forces their hand?

Why must the pharma industry consistently be positioned as an opponent? The government should seek “win-win” situations rather than “victories over …” situations. We still have a long way to go.

Partner Content

3 reasons the point of care is key for improving medication adherence

To overcome adherence obstacles, support needs to begin the moment a prescription is written and continue throughout the patient journey.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Top 25 rare disease brands, by sales

The MM+M Media Summit

From Our Partners

Partner Content

Thought leadership: The key to connecting with healthcare decision-makers

Partner Content

Empowered engagement: How audience-centric strategies drive healthcare marketing success

Partner Content

Will pharma finally reach out to minorities before the government forces their hand?

Partner Content

3 reasons the point of care is key for improving medication adherence

Thank you for accessing MM+M.